-+ 0.00%
-+ 0.00%
-+ 0.00%

SUMMIT THERAPEUTICS INC. : LEERINK PARTNERS RAISES TARGET PRICE TO $13 FROM $11

Reuters·09/29/2026 10:48:59

Please log in to view news